QA: Matinas Biopharma Holdings Inc in us_pharma/2025

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001582554_2026_Matinas_Biopharma_Holdings_Inc.pdf

Logs

Graph

Absolute values for 0001582554, Matinas Biopharma Holdings Inc

  xvar xval
0 AssetsCurrent 4,075,000
1 IntangibleAssetsNetIncludingGoodwill 2,260,000
2 PropertyPlantAndEquipmentNet 138,000
3 remainder_Assets 735,000
4 LiabilitiesCurrent 1,463,000
5 LiabilitiesNoncurrent 915,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 6,844,571
9 ResearchAndDevelopmentExpense -3,244,370
10 remainder_Expenses 3,413,540
11 remainder_Revenues 0
12 remainder_NetIncome -100,690
13 remainder_ComprehensiveNetIncome 54,650
  yvar yval
0 Assets 7,208,000
1 Liabilities 2,378,000
2 Expenses 7,013,741
3 Revenues 0
4 StockholdersEquity 4,830,000
5 NetIncome -7,114,431
6 ComprehensiveNetIncome -7,087,106
7 BaseVar 8,377,540
8 EconomicCapitalRatiobeforeLimitedLiability 0.718
9 EconomicCapitalRatio 2.07

Edgar->Model Mapping

Feature Distribution

Change over Time